Evidence map›Paper›PMID 36365257›Full record

ArticlePharmaceutics2022

Correction: Nguyen et al. Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria.

Phuoc Vinh Nguyen, Clémentine Aubry, Narimane Boudaoud, Alexandra Gaubert, Marie-Hélène Langlois, Mathieu Marchivie, Karen Gaudin, Corinne Arpin, Philippe Barthélémy, Tina Kauss

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Phuoc Vinh NguyenARNA, Inserm U1212, CNRS 5320, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France.ORCID 0000-0002-7421-1623
Clémentine AubryARNA, Inserm U1212, CNRS 5320, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France.
Narimane BoudaoudARNA, Inserm U1212, CNRS 5320, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France.ORCID 0000-0003-0040-8797
Alexandra GaubertARNA, Inserm U1212, CNRS 5320, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France.ORCID 0000-0001-8360-3496
Marie-Hélène LangloisARNA, Inserm U1212, CNRS 5320, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France.
Mathieu MarchivieUMR 5026, University of Bordeaux, CNRS, Bordeaux-INP, ICMCB, 87 Avenue du Dr Albert Schweitzer, CEDEX, 33608 Pessac, France.ORCID 0000-0003-1362-0797
Karen GaudinARNA, Inserm U1212, CNRS 5320, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France.ORCID 0000-0002-0755-145X
Corinne ArpinMFP, CNRS 5234, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France.
Philippe BarthélémyARNA, Inserm U1212, CNRS 5320, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France.ORCID 0000-0003-3917-0579
Tina KaussARNA, Inserm U1212, CNRS 5320, University of Bordeaux, 146 Rue Léo Saignat, CEDEX, 33076 Bordeaux, France.ORCID 0000-0002-0541-6684

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID36365257
PMCPMC9697369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.